Purchase Order 75N91023P00423
Award Date
6/28/23
Potential Completion Date
6/27/24
Potential Value
$21K
Federal Agency
National Cancer Institute
Awardee
Becton, Dickinson And Company
Ultimate Awardee
Becton, Dickinson & Co
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sparks Glencoe, MD 21152, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division a $13,713.30 firm fixed price purchase order for bridge maintenance agreement services. BD Biosciences will perform the services in Bethesda, Maryland over a period of four months concluding in December 2023. As the prime contractor, BD Biosciences specializes in providing research reagents and instruments that...
Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division will provide maintenance services to the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health, under a one-year, firm fixed-price purchase order valued at $24,192.00. The contract supports maintenance of equipment and reagents at the National Cancer Institute's campus in Bethesda, Maryland. No set-aside designation or subcontractors were indicated. Becton...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $25,181.16 delivery order against the Multiple Award Schedule contract vehicle to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division. BD Biosciences will provide maintenance services in support of the National Cancer Institute's research efforts located in Bethesda, Maryland under the firm fixed price contract running from August 1, 2023 through July 31, 2024....
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,468.69 delivery order contract to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for scientific equipment. The prime contractor, Becton, Dickinson and Company BD Biosciences, will provide the equipment under a firm fixed price arrangement. Performance will take place in San Jose, California over a four month period concluding in December 2023. The award...
Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the National Institutes of Health National Cancer Institute for $10,864.80. The contract calls for servicing an instrument used by approximately 75 personnel at the agency to conduct experiments involving costly reagents, animals, and extensive labor hours. Performance will take place in Bethesda, Maryland through April 2024. No set-aside designation was applied. This award is likely associated with...
The National Institutes of Health's National Cancer Institute awarded Becton, Dickinson and Company a $11,681 purchase order contract to provide reagents. The contract has a period of performance from July 11, 2023 through December 26, 2023 and utilizes a firm fixed price payment structure. Reagents will be delivered to Becton, Dickinson and Company's facility in Franklin Lakes, New Jersey to support the National Cancer Institute's research efforts. No subcontractors or set aside designations...
The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a firm-fixed-price purchase order to Becton, Dickinson and Company (BD) for maintenance service on a BD LSR Fortessa SORP cytometer and associated instrumentation, in support of the Surgery Branch of the National Cancer Institute. The contract has a period of performance from August 1, 2021 to July 31, 2026 and a potential value of $123,167.40. No set-aside designation was used for...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH) in the Department of Health and Human Services (HHS), awarded a $38,205.50 firm fixed-price purchase order to Becton, Dickinson and Company (BD) to provide one (1) BD High Throughput Sampler in support of a government-owned BD LSRFortessa Flow Cytometer at the NCI's Center for Cancer Research. This equipment will be used by the NCI's Lymphoid Malignancies Branch. The award did not utilize a small business...
This federal contract award to Becton, Dickinson and Company (BD), a leading medical technology manufacturer, is for the provision of BD Biosciences instrument rental, reagents, quality control material, and instrument supplies to the National Cancer Institute, a component of the Department of Health and Human Services. The contract, valued at $149,960.30, is a delivery order awarded under a larger indefinite delivery/indefinite quantity (IDIQ) vehicle. It does not have a set-aside...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price delivery order to Becton, Dickinson and Company, a leading global medical technology company, to provide reagents, rental equipment, product supply, and maintenance for equipment in the laboratory of pathology. The contract has a potential value of $149,988.00 and a completion date of August 23, 2019. Becton, Dickinson and Company, operating through its IDS division as...